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Okadaic acid (OA), a potent inhibitor o1" protein phosphatases type 1 and type 2A, inhibited thrombin.induced platelet aggregatiGn (IC~o = 0.B 
ltM), [~C]serotonin release and increase in intraccllular Ca :+ ([Ca2"]~) in the same dose dependence. In the absence of thrombin OA increased the 
phosphorylation f 50-kDa protein and 20-kDa myosin li.~ht chain (MLC20). The 50-kDa protein phosphorylation was accomplished within a 
shorter time period and at a lower concentration than was the MLC20, OA decreased the thrombin-induecd phosphorlelation f 47-kDa protein 
and MLC20, although phosphorylation f MLC20 reincreased at hi~hcr concentrations of OA (5-10/dM). Since type 2A phosphatase is more 
sensitive to OA than type 1, these results uggest that type 2A phosphatases are involved in the regulation of Ca:* sisnalin~ in thrombin-induced 
platelet activation. 
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1. INTRODUCTION 
Okadaic acid (OA), a potent inhibitor of protein 
phosphatases type 1 and type 2A [1], is a polyether 
derivative of a C~x-fatty acid which was originally iso- 
lated from the marine sponges of the genus Halichon- 
dria okadai [2]. It is also a potent umor promoter that 
is not an activator of protein kinase C [3]. OA inhibits 
type 2A phosphatase at significantly lower concentra- 
tions than type 1 phosphatase; therefore, it serves as a 
useful probe to investigate the identity of phosphatases 
responsible for the regulation in vivo. It has been estab- 
lished that OA does not affect enzymes uch as protein 
kinase C, Ca-'+/calmodulin-dependent protein kinases, 
cAMP-dependent protein kinase and inositol 1,4,5-tri- 
phosphatase [4,5]. 
Although activation of platelets leads to the phospho- 
rylation of 47-kDa protein (pleckstrin) and 20-kDa 
myosin light chain (MLC20), which are mediated by 
activation of protein kinase C (PKC) and myosin light 
• chain kinase (MLCK), respectively [6,7], little is known 
about the identity of platelet protein phosphatases or
their involvement in controlling platelet function. 
Ill this study, we studied the effects of OA on platelet 
actiwttion, especially that induced by thrombin. The 
relationship between the change of phosphorylation 
with OA exposure and inhibition of platelet function is 
also discussed. 
Correspondence addres.~': M. Higashihara, First Department of Inter- 
nal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, 
Bunkyo-ku, Tokyo 113, Japan. 
2. MATERIALS AND METHODS 
2,1. Matet'ial~' 
Okadaic acid (OA)was purchased fi'om Wako Pharmaceutical L b- 
oratory (Osaka. Japan), OA was stocked at a COl~ccntration f 1 mM 
in ethanol at -20°C. ¢-Throrabin was obtained from Moehida Phar- 
maceutical Ltd. (Tokyo, Japan). [~:P]Phosphoric a id was purchased 
from Amersham Japan (Tokyo, Japan), 
2.2. Platelet f ct~ctio/t e):perimettts 
Studies o1" platelet aggregation and serotonin release [8], LDH re- 
lease IS] and phosphorylation [9]were performed as previously de- 
scribed. [Ca"+]t increase was measured on CAF 100 (Japan Spectro- 
scopic Co, Ltd., Tokyo, Japan), as reported previously [10], 
2.3. Others 
SDS-pol~,acrylamide g l electrophorcsis (SDS-PAGE) was per- 
lbrmed according to the method of Laemmli [1 I]. The radioactive 
platelets were directly subjected to SDS-PAGE, stained, dried on filter 
paper and then exposed to a Kodak X-Omat film. The relative inten- 
sity of each band was quantitated by measuring the absorbanc¢ at430 
nrn using a Shimazu dual-wavelength c romatogram scanner, model 
CS-910, 
3. RESULTS 
3.1. The effect of OA on platelet aggregation 
As shown in Fig. 1, OA is a potent inhibitor of plate- 
let aggregation. Platelet aggregation induced by four 
agonists (ADP0 epinephrine, collagen and thrombin) 
was inhibited by OA in a dose-dependent manner. Incu- 
bation time ofplatelets with OA was also critical for this 
inhibition. In the presence of 0.1/,tM OA the inhibition 
was not apparent even with 60-min incubation except 
in epinephrine. In contrast, about 40% inhibition of the 
aggregation induced by these agonists was observed 
even with 2-min incubation in the presence of 10/.tM 
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Fig, I. Inhibition of platelet aggregation by okadaie acid (OA}. (A) 
ADP (10/aM); (B) epinephrine (i0 ~M); (C) collagen (2 gg/ml); (D) 
thrombin (0,1 U/ml), PRP (A, B. C) or washed platetets (D) were 
preineubated with OA for 2 rain. 10 rain, 30 rain or 60 rain before the 
addition of agonists. Three different concentrations (0.1/aM, 0.4/aM 
and l/aM) of OA wer~ used. Each plot represents percent maximum 
aggregation (mean of three xperiments), o--o, control (buffer alone).' 
A--A, 0.1 ~tM OA; R -m, 0.4/tM OA; v.-v, 1/aM OA. 
OA (not shown)..No apparent release of LDH was de- 
tected with 60-min incubation in the presence of 10/aM 
OA. ICs0 of aggregation with 10-min incubation was 
about 0.5,uM, 0.5/.tM, 0.7/aM or 0.8/aM OA for ADP 
(10/aM), epinephrine (10/aM), collagen (2 pg/mi) or 
thrombin (13.1 U/ml), respectively. Moreover, the inhib- 
itory effects of OA on these aggregations were dimin- 
ished with increasing concentrations of agonists (not 
shown). 
3.2. The effect of OA on thrombin.induced platelet acti. 
ration 
Fig. 2A shows the inhibition of thrombin-induced 
[~4C]serotonin release by OA. GA inhibited serotonin 
release in a dose- and time-dependent manner. As 
shown in Fig, 2B, the inhibition was decreased with an 
increase in the concentration of thrombin. OA also in- 
hibited thrombin-induced increases in intracellular Ca "-~ 
([Ca"*]i) (Fig. 3A). The basal level of [Ca'-+]i was lower 
in the presence of OA (over 1/aM) than in the control. 
As shown in Fig. 3B, inhibition was observed in both 
the presence and absence of extracellular Ca a+ (in the 
presence of 2 mM EGTA), suggesting that OA may 
inhibit both Ca 2. influx and Ca :+ release from the intra- 
cellular Ca "-+ pool. The extent of inhibition was greater 
in the pre~ence of extraeellular Ca `-+ (1 raM) than in the 
absence of Ca ~-+. Fig. 3C shows the dose and time de- 
pendence of the inhibition of [Ca"+]~ increase by throm- 
bin (0.1 U/ml) in the presence and absence of extrace!!u- 
lar Ca ~-+. Platelets incubated with 1/aM OA for 30 min 
revealed almost complete inhibition of [Ca2÷]~ increase 
in both conditions, The dependence was similar to those 
Fig, 2, Inhibition of thrombin.indaced [t4Clserotonin release by oka- 
daic acid (OA). (A) Washed platelets were preincubated with various 
concentrations of OA for 2 rain, 10 min, 3(} rain or 60 rain and then 
further incubated with thrombin (0. I U/ml) for I additional rain. Each 
spot represents percent serotonin relea~ (mean of three ~periments). 
l--e. control (buffer alone); A--*, 0.1 /aM OA; m--m, 0,4/aM OA; 
v-v, I/aM OA; o--o, 5 ~M OA. (B) Washed platdets w~re prein- 
cubated with OA for 10 rain and then further incubated with various 
concentrations f thrombin for I additional rain. I--o, control (buffer 
alone); A--A. 0.I/aM OA; l--m. 0.4 aM OA; v-v, I/aM OA; o--o, 
5/aM OA. 
for platelet aggregation and serotonin release (see Figs. 
i D and 2A), 
3.3. OA induced phosphoo,lation of platelet protein 
To investigate the relation between the inhibitory ef- 
fects of OA on platelet function and protein phospho- 
rylation, the effect of OA on platelet protein phospho- 
rylation was examined, 32P-labefled platelets were ex- 
posed to OA, and the phosphorylated proteins were 
analyzed by SDS-PAGE followed by autoradiography. 
Upon the addition of l /aM OA for l0 rain, several 
phosphorylated bands were observed; most notable was 
the prominent increase in 50-kDa and 20-kDa proteins. 
Fig. 4A shows the time course of phosphorylation of 
both proteins. The phosphorylation of 50-kDa protein 
in the presence of OA (1/aM) was increased faster than 
that of 20-kDa protein, and the phosphorylation level 
reached a plateau over a 20-rain incubation time. In 
contrast, the phosphorylation of 20-kDa protein in the 
presence of OA (l/aM) increased much slower and did 
not reach maximum even at 60 rain incubation time. 
Fig. 4B shows the extent of phosphotTlation of both 
proteins as a function of  OA concentration (see also 
inset in Fig. 4B). The phosphorylation of 50-kDa pro- 
tein became apparent over 0.4 ,oM OA and almost 
reached a plateau over 1 /aM OA, while higher OA 
concentration was required for the phosphorylation of
20-kDa protein. The 20-kDa protein was immunopre- 
cipitated by rabbit anti-human platelet myosin anti- 
body; therefore, this was concluded to be the 20-kDa 
myosin light chain (MLC20) (not shown). In contrast, 
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Fig. 3. Inhibition of thrombin.induced increase in [Caa+]~ by okadaic 
acid (OA). (A) Thrombin (0.1 U/ml)-induced increase in [Ca2+]~. Con- 
trol (left); platelets pretrcated with OA (5/.tM) for 10 rain (righ0, (B) 
Increase in [Ca~']~ was monitored in the presence of I mM Ca `-+ or 2 
mM EGTA. Washed platelets were preincubatcd with or without i
,uM OA for 10 rain and thrombin (0,1 U/ml) was added. Each value 
is mean -+ SD of five experiments. (C) Washed platelets were preincu- 
bated with OA for 10 rain, 30 rain, or 60 min and increase in [Caa+]t 
was monitored in the presence of I mM Ca ~+ or 2 mM EOTA. Each 
plot is a mean of three xperiments, o---o, control (buffer alone); 4-=,  
0.1 ~M OA; m---re. 0.4BM OAt v -v ,  1/aM OA. 
the phosphorylation of 47-kDa protein (pleckstrin), 
which is known to be a substrate of protein kinase C, 
was not increased in the presence of OA (see lane 8 of 
inset in Fig. 4B). The phosphorylation of these two 
proteins was independent of external Ca:*, because the 
levels of phosphorylation were the same even in the 
presence of 2 mM EGTA (not shown). 
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Fil]. 4. Effect of okadaic acid (OA) on the phosphorylation f platelet 
proteins. (A) The extent of phosphorylation f 20-kDa and 50-kDa 
proteins with various incubation times of OA (l pM). A-A, 50-kDa 
protein; o- -e ,  20-kDa protein. [] and i ,  47-kDa and 20-kDa proteins 
phosphorylated by thrombin (0.I U/ml), respectively. (B) The extent 
of phosphorylation f 20.kDa and 50-kDa proteins with various con- 
centrations of OA. The incubation time was l0 rain. A--A, 50-kDa 
protein; o--o,  20-kDa protein. Inset shows autoradiogram. (Lane 1 
and 9) buffer alone; (lane 2) 0.01/.tM OA; (lane 3) 0.1/.tM OA; (lane 
4) 0,4/~M OA; (lane 5) 1/.tM OA; (lane 6) S,uM OA; (lane 7) 10/LM 
OA; (lane B) 0, l U/ml thrombin for I rain. The band of 27-kDa protein 
(*) was also detected. (C) lnhibltien of thrombin-induced 47.kDa 
protein phosphorylation byOA. Plat,fiefs were preincubatcgl with var- 
ious concentrations of OA for 10 rain and further incubated with 
thrombin (0.1 U/ml) for 1 more rain. []--~, 47-kDa protein; m--m, 
20-kDa protein. 
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Pretreatment with OA led to the inhibition of phos- 
phorylation of 20-kDa and 47-kDa proteins induced by 
thrombin. As shown in Fig. 4C, phosphorylation of
47-kDa protein by thrombin (0.1 U/ml) was inhibited 
intensively with exposure of over 1/aM OA for 10 rain 
in a dose-dependent manner. Moreover, the inhibitory 
effects of OA on this phosphorylation were diminished 
with increased concentration f thrombin (not shown). 
The phosphorylation of MLC20 was also decreased 
with exposure of OA, but at higher concentrations of 
OA (5-10/aM) the phosphorylation reincreased. 
4. DISCUSSION 
Although some phosphatases of human platelets, in- 
eluding type 1 and type 2A, have been partially purified 
[12,13], the role of phosphatases in the platelet function 
remains unknown. The goal of this study is to shed light 
on the role of phosphatases in the platelet activation. 
The probe we employed is okadaic acid (OA), a potent 
inhibitor of phosphatases type 1 and type 2A [1]. It is 
known that OA inhibits type 2A phosphatase at rela- 
tively lower concentration and type 1 at relatively 
higher concentration [14]. 
OA inhibited platelet aggregation i duced by four 
agonists: ADP, epinephrine, collagen and thrombin 
(Fig. 1), as well as serotonin release and increase in 
[Ca:+]t induced by thrombin (Figs. 2 and 3). For throm- 
bin, these inhibitions were observed in the same dose- 
and time-dependent manner. 
Hence w~ e~amined the change in the phosphoryla- 
tion of intrinsic platelet proteins induced by OA expo- 
sure. OA predominantly induced the phosphorylation 
of proteins at two molecular weight regions, 50-kDa 
and 20-kDa (MLC20) (Fig. 4A). While this study was 
in process, Lorea reported [15] that the 50-kDa band is 
composed of three basic polypeptides (pI 6.5-7.0), al- 
though the function of these proteins is unknown. 
The increase in the phosphorylation f the 50-kDa 
protein reached maximum within 20 min while the 
phosphorylation f the MLC20 kept increasing even 
after 60 min of preincubation with 1/xM OA (Fig. 4A). 
This suggests hat a great deal oftime is required for OA 
to penetrate the membranes a shown by Klumpp et al. 
[16], and that higher OA may be required for the phos- 
phorylation of the MLC20 than for that of the 50-kDa 
protein. We recently suggested that the phosphatase 
which dephosphorylated smooth muscle myosin is type 
I-like phosphatase and is inhibited by OA at relatively 
high concentration [17], and that platelet myosin has a 
functional property similar to that of smooth muscle 
myosin [18]. Therefore, it is understandable that the 
phosphorylation f platelet MLC20 was observed with 
exposure to higher concentration of OA (1-10 /~M) 
(Fig. 4B). Because the free calmodulin concentration is 
thought o be greater than 10/~M [19] and the Kd of 
MLCK for Ca-'+/calmodulin is less than 1 nM [20]+ if 
type I phosphatas¢ is inhibited by OA, there is enough 
MLCK activity tc phosphorylate MLC20 even in the 
resting state: [Ca'-']+ is 0.5-I x 10 -7 M. 
On  the other hand, the increase in the phosphoryla- 
tion of the 50-kDa protein may be due to the inhibition 
of type 2A phosphatases, which are more sensitive to 
OA, since the increase in the phosphorylation was ac- 
complished within a shorter time period (Fig. 4A) and 
at a lower concentration than in the case of the MLC20 
(Fig. 4B). However, it is still not clear whether type 2A 
phosphatase d phosphorylates he50-kDa protein and 
therefore OA treatment increases this phosphorylation, 
or whether type 2A phosphatase inactivates puta'.ive 
protein kinase, which phosphorylatcs the 50-kDa pro- 
teins. The kinase responsible for the phosphorylation f 
the 50-kDa protein is unlikely to be Ca2÷-activated ki- 
nase since [Ca:+]~ was reduced when the cells were 
treated with OA alone (Fig. 3A). 
It has been known that the MLC20 and 47-kDa pro- 
tein (pleckstrin) are phosphorylated during the platelet 
activation induced by thrombin [6,7]. In this study, we 
found that OA inhibited thrombin-induced platelet ag- 
gregation, serotonin release and increase in [Ca-~+]i, and 
that the phosphorylation of both proteins decreased 
with preincubation with OA (higher than 1/~M) for 10 
rain (Fig. 4C). These effects of OA are probably due to 
the inhibition of [Ca:+]~ increase, since it is known that 
the phosphorylations of both proteins are Ca'++-depend - 
ent and that the increase of [Ca-'+]~ isprerequisite for the 
platelet activation. OA inhibited the increase in [Ca:+]~ 
both in the presence and absence of the extraceilular 
Ca :+ (Fig. 3), therefore, the inhibition seems to be attri- 
buted both to Ca 2÷ mobilization from extracellular 
space and intracellular store; that is, the inhibitory ef- 
fect of OA on [Ca-'+]~ increase may be due to the modu- 
lation of Ca > channels (surface membrane Ca :+ chan- 
nels and endoplasmic reticulum Ca :+ channels). How- 
ever, we cannot neglect the possibility that OA inhibits 
the phosphoinositide-signaling cascade which decreases 
the production of inositol triphosphate. The 
phosphatases responsible for the change in Ca :+ signal- 
ing are likely to be type 2A phosphatases since the mod- 
ulation of Ca -'+ mobilization occurred at the lower OA 
concentration than that required for the increase in the 
20-kDa phosphorylation which is due to the inhibition 
of type I phosphatases. At higher concentrations of OA, 
phosphorylation f MLC20 by thrombin re-increased 
(Fig. 4C), although [Ca-'+]i was decreased (Fig. 3C). This 
can be explained by the fact that type l-like phosphat- 
ase, which is responsible for the dephosphorylation of 
MLC20, is inhibited at relatively higher OA concentra- 
tions. On the other hand, the phosphorylation f 47- 
kDa protein was not increased even at higher OA con- 
centrations, uggesting that the phosphatase r sponsible 
for the dephosphorylation of the 47-kDa protein is nei- 
ther type 1 nor type 2A. 
It is possible that the 50-kDa protein is involved in 
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the regulation of platelet activation either directly or via 
changing [Ca:+]~, since the inhibition of platelet activa- 
tion by OA treatment and 50.kDa protein phosphoryla- 
tion occurred at the same dose and with the same time 
dependence (Figs. I, 2, 3 and 4). However, further stud- 
ies are required to determine whether or not the phos- 
phorylation of the 50-kDa proteins is involved in the 
regulation of platelet function. 
It is still not clear how resting [Ca""]~ decreases with 
OA treatment (Fig. 3A). However, modification of Ca-'" 
signaling by phosphorylation has been suggested. 
Witcher et al. [21] recently reported that the activity of 
Ca:'- release claanneis of the cardiac sarcoplasmic retic- 
ulum (SR) is inhibited by Ca2+-dependent phosphoryla- 
tion. We found previou.qy [22] that the microinjection 
of Ca-'Vealmodulin-dependent kinase inhibitor peptide 
into single isolated smooth muscle cells markedly en- 
hances the transient Ca 2+ increase after the depolariza- 
tion. Recently we also found that calmodulin-dependent 
kinase may modulate the smooth muscle surface mem- 
brane Ca 2+ channel [23]. These results suggest hat pro- 
tein kinase-protein phosphatase systems modulate the 
Ca -~÷ homeostasis. Therefore, our results can be ex- 
plained by the fact that OA inhibits the platelet phos- 
phatase activity so as to increase the phosphorylation 
of the Ca"" channel which results in a decrease in the 
[Ca-~'-]i. 
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